Eisai
4523.T
#1457
Rank
$11.81 B
Marketcap
$41.18
Share price
-0.02%
Change (1 day)
-25.99%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Operating Margin for Eisai (4523.T)

Operating Margin as of March 2024 (TTM): 8.71%

According to Eisai's latest financial reports and stock price the company's current Operating Margin is 8.71%. At the end of 2022 the company had an Operating Margin of 7.20%.

Operating Margin history for Eisai from 2009 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
20227.20%-11.48%
20218.14%-55.81%
202018.41%32.3%
201913.92%8.72%
201812.80%19.65%
201710.70%16.13%
20169.21%95.26%
20154.72%-51.35%
20149.70%-22.12%
201312.45%-14.77%
201214.61%9.51%
201113.34%44.24%
20109.25%2.57%
20099.02%275.12%
20082.40%-85.31%
200716.37%2.41%
200615.98%-2.8%
200516.44%-0.36%
200416.50%10.26%
200314.96%2.95%
200214.53%22.73%
200111.84%

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.